Advanced search×

A new kaolin-based haemostatic bandage compared with manual compression for bleeding control after percutaneous coronary procedures.

Eur Radiol 21(8):1687-91 (2011) PMID 21476127

Bleeding and vascular access site complications are an important cause of morbidity after percutaneous femoral procedures. New haemostatic dressings have been developed to control heavy bleeding. To evaluate the efficacy of a new kaolin-based haemostatic bandage for femoral artery closure after diagnostic or interventional procedures compared with manual compression. The first pilot European trial using this haemostatic bandage was performed at the in Milan, Italy. Two-hundred patients (71% male, mean age 66 ± 11 years) undergoing angiography or PCI via a femoral approach were randomised to the haemostatic bandage (n = 100) or manual compression (n = 100) following sheath removal. The mean active clotting time (ACT) at haemostasis was 146 ± 24 s (range 98-198 s). Haemostasis was achieved in 5.4 ± 1.5 min with the bandage vs 25 ± 15 min after manual compression, p 

DOI: 10.1007/s00330-011-2117-3
Version: za2963e q8za0 q8zb6 q8zcf q8zd1 q8ze4 q8zf1 q8zg2

Similar articles you may find interesting…

  1. Enhancement of vascularization and granulation tissue formation by growth factors in human platelet-rich plasma-containing fragmin/protamine...

    J Biomed Mater Res B Appl Biomater 97(2):373-80 (2011) PMID 21432994

    The purpose of this study was to evaluate effects of human platelet-rich plasma (PRP)-containing fragmin/protamine microparticles (F/P MPs) as a protein carrier on neovascularization and granulation tissue formation. Frozen and thawed PRP contains high concentrations of various growt...
  2. The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration

    J Am Coll Cardiol 41(3):9 (2003) PMID 12575965

    The ACT and aPTT are sensitive to IV dalteparin at clinically relevant doses. These data suggest that the ACT may be useful in monitoring the anticoagulant effect of intravenously administered dalteparin during PCI....
  3. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular ...

    Am Heart J 158(2):5 (2009) PMID 19619702

    Arrhythmia devices can be implanted safely in patients with high thromboembolic risk without interruption of warfarin. This strategy may be associated with reduced risk of significant pocket hematoma compared with dalteparin bridging....